• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸哌甲酯长期影响的实验研究

Experimental studies on the long-term effects of methylphenidate hydrochloride.

作者信息

Dunnick J K, Hailey J R

机构信息

National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.

出版信息

Toxicology. 1995 Nov 30;103(2):77-84. doi: 10.1016/0300-483x(95)03109-s.

DOI:10.1016/0300-483x(95)03109-s
PMID:8545847
Abstract

Toxicology and carcinogenesis studies of methylphenidate hydrochloride, a drug used in the treatment of attention-deficient disorders, were performed in F344 rats and B6C3F1 mice. In these studies, methylphenidate hydrochloride was administered for 2 years at doses of 0, 100, 500 or 1000 ppm in the feed to rats and at doses of 0, 50, 250, 500 ppm to mice in groups that consisted of 50 animals/dose/sex/species. The average amount of methylphenidate consumed per day was estimated to be 4-47 mg/kg/day for rats and 5-67 mg/kg/day for mice. Survival was similar in dosed and control groups. An increase in benign tumors of the liver and increased liver weights were observed in male and female mice at the high dose. An increase in hepatoblastomas was also seen in high dose male mice. Methylphenidate was not mutagenic in the Salmonella assay system, and it is hypothesized that this tumorigenic effect might be due to nongenotoxic effects of the chemical such as an increase in cell proliferation. Increased incidences of neoplasms were not seen in rats. However, there was a notable decrease in mammary gland fibroadenomas in female rats and a marginal decrease in benign pheochromocytomas in male rats. Epidemiology studies of methylphenidate have found no evidence of a carcinogenic effect in humans and like our findings in rats, report a less than expected rate of cancers in patients taking methylphenidate.

摘要

盐酸哌甲酯是一种用于治疗注意力缺陷障碍的药物,对其进行了毒理学和致癌性研究,实验对象为F344大鼠和B6C3F1小鼠。在这些研究中,给大鼠喂食含0、100、500或1000 ppm盐酸哌甲酯的饲料,持续2年;给小鼠喂食含0、50、250、500 ppm盐酸哌甲酯的饲料,每组每种性别各50只动物。据估计,大鼠每天摄入的盐酸哌甲酯平均量为4 - 47毫克/千克/天,小鼠为5 - 67毫克/千克/天。给药组和对照组的存活率相似。高剂量组的雄性和雌性小鼠均出现肝脏良性肿瘤增加以及肝脏重量增加的情况。高剂量组的雄性小鼠还出现肝母细胞瘤增加的现象。盐酸哌甲酯在沙门氏菌检测系统中无致突变性,据推测,这种致癌作用可能是由于该化学物质的非遗传毒性效应,如细胞增殖增加。大鼠未出现肿瘤发生率增加的情况。然而,雌性大鼠的乳腺纤维腺瘤发生率显著降低,雄性大鼠的良性嗜铬细胞瘤发生率略有降低。对盐酸哌甲酯的流行病学研究未发现其对人类有致癌作用的证据,并且与我们在大鼠中的研究结果类似,服用盐酸哌甲酯的患者癌症发生率低于预期。

相似文献

1
Experimental studies on the long-term effects of methylphenidate hydrochloride.盐酸哌甲酯长期影响的实验研究
Toxicology. 1995 Nov 30;103(2):77-84. doi: 10.1016/0300-483x(95)03109-s.
2
NTP Toxicology and Carcinogenesis Studies of Methylphenidate Hydrochloride (CAS No. 298-59-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).盐酸哌甲酯(化学物质登记号:298 - 59 - 9)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1995 Jul;439:1-299.
3
NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).美国国家毒理学计划关于依美司坦(化学物质登记号:37319-17-8)在F344/N大鼠和B6C3F1小鼠中的毒理学及致癌性研究的技术报告(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2004 May(512):7-289.
4
Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).银杏叶提取物(CAS编号90045-36-6)在F344/N大鼠和B6C3F1/N小鼠中的毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2013 Mar(578):1-183.
5
Toxicology and carcinogenesis studies of androstenedione (CAS No. 63-05-8) in F344/N rats and B6C3F1 mice (gavage studies).雄烯二酮(CAS编号:63-05-8)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2010 Sep(560):1, 7-31,33-171 passim.
6
NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).五氯苯甲醚(CAS编号:1825-21-4)在F344大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1993 Apr;414:1-284.
7
NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).NTP关于β-月桂烯(CAS编号:123-35-3)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究的技术报告(灌胃研究)。
Natl Toxicol Program Tech Rep Ser. 2010 Dec(557):1-163.
8
Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).C.I.颜料红3(CAS编号2425-85-6)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1992 Mar;407:1-289.
9
Toxicology and carcinogenesis studies of benzophenone (CAS No. 119-61-9) in F344/N rats and B6C3F1 mice (feed studies).二苯甲酮(CAS编号:119 - 61 - 9)在F344/N大鼠和B6C3F1小鼠中的毒理学和致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 2006 Feb(533):1-264.
10
Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).邻硝基甲苯砜(化学物质登记号:88-72-2)在F344/N大鼠和B6C3F(1)小鼠中的毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 2002 May(504):1-357.

引用本文的文献

1
Nutritional supplements for the treatment of ADHD.用于治疗注意力缺陷多动障碍的营养补充剂。
Child Adolesc Psychiatr Clin N Am. 2014 Oct;23(4):883-97. doi: 10.1016/j.chc.2014.05.002. Epub 2014 Aug 12.
2
Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.使用兴奋剂治疗注意力缺陷/多动障碍:临床方法与挑战。
Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12f01472. Epub 2013 Mar 28.
3
Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.
ω-3 脂肪酸补充剂治疗注意缺陷多动障碍症状儿童:系统评价和荟萃分析。
J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991-1000. doi: 10.1016/j.jaac.2011.06.008. Epub 2011 Aug 12.
4
Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.注意缺陷多动障碍药物治疗的不良反应:流行病学、预防与管理
CNS Drugs. 2008;22(3):213-37. doi: 10.2165/00023210-200822030-00003.
5
Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.儿童和青少年注意力缺陷多动障碍的治疗:安全性考量
Drug Saf. 2007;30(1):17-26. doi: 10.2165/00002018-200730010-00003.
6
Stimulant drugs.兴奋剂药物。
Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I27-43. doi: 10.1007/s007870070017.
7
Safety issues in the use of methylphenidate. An American perspective.哌甲酯使用中的安全问题。美国视角。
Drug Saf. 1997 Sep;17(3):143-8. doi: 10.2165/00002018-199717030-00001.